125 related articles for article (PubMed ID: 10394456)
1. [Fulminant hepatitis in two children treated with sulfasalazine for Crohn disease].
Besnard M; Debray D; Durand P; Fabre M; Chardot C; Cézard JP
Arch Pediatr; 1999 Jun; 6(6):643-6. PubMed ID: 10394456
[TBL] [Abstract][Full Text] [Related]
2. Sulfasalazine intolerance. A retrospective survey of the reasons for discontinuing treatment with sulfasalazine in patients with chronic inflammatory bowel disease.
Nielsen OH
Scand J Gastroenterol; 1982 Apr; 17(3):389-93. PubMed ID: 6127793
[TBL] [Abstract][Full Text] [Related]
3. Sulfasalazine-induced fulminant hepatitis in pediatric Crohn's disease: report of two cases.
Besnard M; Debray D; Durand P; Cézard JP; Navarro J
J Pediatr Gastroenterol Nutr; 1998 Jan; 26(1):119-20. PubMed ID: 9443132
[No Abstract] [Full Text] [Related]
4. Hepatotoxicity after treatment with sulfasalazine.
Haines JD
Postgrad Med; 1986 May; 79(6):193-4, 197-8. PubMed ID: 2871549
[TBL] [Abstract][Full Text] [Related]
5. Sulfasalazine-induced fulminant hepatic failure and necrotizing pancreatitis.
Rubin R
Am J Gastroenterol; 1994 May; 89(5):789-91. PubMed ID: 7909645
[TBL] [Abstract][Full Text] [Related]
6. Stevens-Johnson syndrome on treatment with sulfasalazine for Crohn's disease: Need for a multidisciplinary approach.
Viola A; Caltagirone AM; Campisi G; Guarneri G; Cappello M
Turk J Gastroenterol; 2019 Feb; 30(2):211-212. PubMed ID: 30541717
[No Abstract] [Full Text] [Related]
7. Sulfasalazine-induced hepatotoxicity in children with inflammatory bowel disease.
Boyer DL; Li BU; Fyda JN; Friedman RA
J Pediatr Gastroenterol Nutr; 1989 May; 8(4):528-32. PubMed ID: 2566669
[TBL] [Abstract][Full Text] [Related]
8. Sulfasalazine-associated encephalopathy in a patient with Crohn's disease.
Schoonjans R; Mast A; Van den Abeele G; Dewilde D; Achten E; Van Maele V; Pauwels W
Am J Gastroenterol; 1993 Oct; 88(10):1759-63. PubMed ID: 8105680
[TBL] [Abstract][Full Text] [Related]
9. Comparative tolerability of treatments for inflammatory bowel disease.
Stein RB; Hanauer SB
Drug Saf; 2000 Nov; 23(5):429-48. PubMed ID: 11085348
[TBL] [Abstract][Full Text] [Related]
10. [Hypersensitivity to 5-aminosalicylic acid. Value of desensitization by oral route].
Lachaux A; Le Gall C; Loras-Duclaux I; Aboufadel A; Hermier M
Arch Pediatr; 1997 Feb; 4(2):144-6. PubMed ID: 9097825
[TBL] [Abstract][Full Text] [Related]
11. Liver transplantation for disulfiram-induced fulminant hepatic failure.
Mohanty SR; LaBrecque DR; Mitros FA; Layden TJ
J Clin Gastroenterol; 2004 Mar; 38(3):292-5. PubMed ID: 15128079
[TBL] [Abstract][Full Text] [Related]
12. Sulfasalazine-associated encephalopathy in a patient with Crohn's disease.
Schoonjans R; Mast A; Van Den Abeele G; Dewilde D; Achten E; Van Maele V; Pauwels W
Am J Gastroenterol; 1993 Sep; 88(9):1416-20. PubMed ID: 8103282
[TBL] [Abstract][Full Text] [Related]
13. Fulminant hepatic failure in a child as a potential adverse effect of trimethoprim-sulphamethoxazole.
Simma B; Meister B; Deutsch J; Sperl W; Fend F; Ofner D; Margreiter R; Vogel W
Eur J Pediatr; 1995 Jul; 154(7):530-3. PubMed ID: 7556317
[TBL] [Abstract][Full Text] [Related]
14. Salazopyrin in the management of Crohn's disease. The Japanese Research Committee for Crohn's disease.
Gastroenterol Jpn; 1985 Feb; 20(1):71-81. PubMed ID: 2862089
[TBL] [Abstract][Full Text] [Related]
15. [Clinical effect of salazosulfapyridine (salazopyrin) in Crohn's disease. A controlled double-blind investigation].
Anthonisen P; Bárány F; Folkenborg O; Holtz A; Jarnum S; Kristensen M; Riis P; Walan A; Worning H
Ugeskr Laeger; 1974 Aug; 136(32):1798-802. PubMed ID: 4153180
[No Abstract] [Full Text] [Related]
16. Cholestasis in Crohn's disease: a diagnostic challenge.
Hilzenrat N; Lamoureux E; Sherker A; Cohen A
Can J Gastroenterol; 1997; 11(1):35-7. PubMed ID: 9113796
[TBL] [Abstract][Full Text] [Related]
17. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
Nørgård BM
Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
[TBL] [Abstract][Full Text] [Related]
18. The clinical effect of salazosulphapyridine (Salazopyrin r) in Crohn's disease. A controlled double-blind study.
Anthonisen P; Barany F; Folkenborg O; Holtz A; Jarnum S; Kristensen M; Riis P; Walan A; Worning H
Scand J Gastroenterol; 1974; 9(6):549-54. PubMed ID: 4153646
[No Abstract] [Full Text] [Related]
19. Liver transplantation for disulfiram-induced hepatic failure.
Rabkin JM; Corless CL; Orloff SL; Benner KG; Flora KD; Rosen HR; Olyaei AJ
Am J Gastroenterol; 1998 May; 93(5):830-1. PubMed ID: 9625138
[TBL] [Abstract][Full Text] [Related]
20. Pleuropericardial effusion after 37 years of sulfasalazine therapy.
Gupta R; Hennebry TA; Kinasewitz GT
J Cardiovasc Med (Hagerstown); 2012 Aug; 13(8):541-3. PubMed ID: 21228714
[No Abstract] [Full Text] [Related]
[Next] [New Search]
